Finance

Results: 481-492 of 21077

PR Newswire associated0

Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology

Perma-Pipe International Holdings, Inc. Announces $43 Million Contract Award in the Middle East Region

Orexo announces positive topline data from clinical study of OX640 in subjects with and without allergic rhinitis

Plan to tackle greedy ticket touts and give power back to fans

TrailRunner International Announces New Leadership Appointments

Chemify, a deep tech chemical science company combining chemistry, robotics and AI at scale to digitally design, discover and make new molecules, announced today that Dr. Alastair Leighton has joined as Chief Operating Officer (COO). With almost three decades in the biopharma industry working at leading global pharmaceutical companies, Dr. Leighton brings a wealth of experience in manufacturing, supply chain operations and commercial strategy. (Photo: Business Wire)

Chemify Hires Biopharma Veteran Dr. Alastair Leighton as Chief Operating Officer

Institute of Molecular and Clinical Ophthalmology Basel Spinout RhyGaze Closes USD 86 Million Series A Round to Further Novel Gene Therapy for Vision Restoration

Tiziana Announces Reduction of Side Effects Commonly Seen with Discontinuation of GLP-1 Agonists with Nasal Anti-CD3

Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore

Compass Pathways Announces Pricing of Underwritten Offering

iTeos Announces 2025 Strategic Priorities and Anticipated Milestones

Ronald S. Lauder to Retire from The Estée Lauder Companies’ Board of Directors